Bronchiectasis

Definition

Bronchiectasis is a chronic respiratory condition characterized by permanent, abnormal dilation and scarring of the bronchi and bronchioles due to repeated infection and inflammation.

Key Characteristics:

Irreversible airway dilation
Chronic productive cough
Recurrent respiratory infections
Impaired mucociliary clearance

Etymology:

Broncho- = relating to bronchi
-ectasis = dilation or expansion
Greek origin: “bronkhos” (windpipe) + “ektasis” (stretching)

Types of Bronchiectasis

Classification by Etiology

Congenital Bronchiectasis

• Cystic fibrosis (most common)
• Primary ciliary dyskinesia
• Alpha-1 antitrypsin deficiency
• Immunodeficiency disorders
• Congenital airway abnormalities

Acquired Bronchiectasis

• Post-infectious (pneumonia, TB, whooping cough)
• Aspiration-related
• COPD-associated
• Autoimmune diseases
• Foreign body aspiration

Morphological Classification

🟢

Cylindrical

Uniform dilation, mild form

🟡

Varicose

Irregular dilation, moderate

🔴

Cystic/Saccular

Severe, cyst-like dilation

Etiological Factors

Memory Aid: “BRONCHI”

B – Bacterial infections (Staph, Pseudomonas)

R – Respiratory tract infections

O – Obstruction (foreign body, tumor)

N – Neonatal/congenital disorders

C – Cystic fibrosis

H – Hypersensitivity reactions

I – Immunodeficiency states

Clinical Pearl

The “vicious cycle” of bronchiectasis: infection → inflammation → airway damage → impaired clearance → more infection

Most Common Causes

1. Cystic fibrosis (40% of cases)
2. Post-infectious sequelae (25%)
3. Primary ciliary dyskinesia (10%)
4. Immunodeficiency (8%)
5. Idiopathic (17%)

High-Risk Populations

• Children with recurrent pneumonia
• Adults with COPD exacerbations
• Immunocompromised patients
• Patients with gastroesophageal reflux

Prevention Focus

Early recognition and treatment of respiratory infections, vaccination programs, and genetic counseling for familial cases.

Pathophysiology

The Vicious Cycle of Bronchiectasis

Initial Insult
(Infection, Inflammation, Obstruction)

↓

Airway Inflammation
(Neutrophil infiltration, Cytokine release)

↓

Structural Damage
(Bronchial wall destruction, Loss of elasticity)

↓

Impaired Clearance
(Ciliary dysfunction, Mucus stasis)

↓

Secondary Infection
(Bacterial colonization, Biofilm formation)

↑ (Cycle continues)

Microscopic Changes

Epithelial Changes: Loss of ciliated epithelium, squamous metaplasia, goblet cell hyperplasia
Inflammatory Infiltrate: Neutrophils, lymphocytes, plasma cells in bronchial walls
Structural Changes: Smooth muscle hypertrophy, cartilage destruction, fibrosis

Functional Consequences

Ventilation-Perfusion Mismatch

Impaired gas exchange due to airway obstruction

Airflow Limitation

Decreased FEV1, increased airway resistance

Impaired Host Defense

Reduced mucociliary clearance, bacterial colonization

Signs & Symptoms

Subjective Data (Symptoms)

Primary Symptoms

Chronic productive cough (>8 weeks)
Purulent sputum (yellow, green, or blood-tinged)
Dyspnea on exertion progressing to rest
Chest pain (pleuritic type)
Fatigue and malaise

Systemic Symptoms

Recurrent fever and chills
Night sweats
Weight loss and anorexia
Decreased exercise tolerance

Objective Data (Signs)

Respiratory Signs

Coarse crackles (wet rales)
Rhonchi and wheeze
Diminished breath sounds
Prolonged expiratory phase
Use of accessory muscles

General Physical Signs

Digital clubbing (in advanced cases)
Cyanosis (central or peripheral)
Barrel chest configuration
Signs of right heart failure (cor pulmonale)

Memory Aid: “4 C’s of Bronchiectasis”

🗯️

Chronic Cough

Productive, persistent

🦠

Copious Sputum

Purulent, foul-smelling

🔊

Coarse Crackles

Wet, persistent rales

🫁

Clubbing

Digital, in severe cases

Nursing Assessment

Comprehensive Nursing Assessment Framework

Primary Assessment (ABCDE)

Airway – Patency, secretion clearance
Breathing – Rate, depth, effort, oxygen saturation
Circulation – Heart rate, blood pressure, perfusion
Disability – Neurological status, consciousness
Exposure – Temperature, skin integrity

Focused Respiratory Assessment

Respiratory rate and rhythm
Oxygen saturation (pulse oximetry)
Breath sounds auscultation
Chest expansion and symmetry
Use of accessory muscles

History Taking

Key Questions

• Duration and characteristics of cough
• Sputum color, consistency, volume
• Dyspnea progression and triggers
• Family history of lung disease
• Childhood respiratory infections
• Smoking history
• Environmental exposures

Physical Examination

Inspection

Chest shape, breathing pattern, cyanosis, clubbing

Palpation

Chest expansion, fremitus, lymph nodes

Percussion

Dullness over consolidated areas

Auscultation

Breath sounds, adventitious sounds

Functional Assessment

Activities of Daily Living

• Exercise tolerance
• Sleep pattern disturbances
• Nutritional status
• Self-care abilities
• Quality of life impact
• Psychosocial adaptation
• Support system availability

Assessment Pearls for Nurses

1. Sputum Assessment: Document color, consistency, volume (measured in mL), and odor. Normal production is <30mL/day.

2. Dyspnea Scale: Use standardized scales (Borg Scale, MRC Dyspnea Scale) for objective measurement.

3. Digital Clubbing: Check nail bed angle (>180° indicates clubbing) and perform Schamroth’s test.

4. Infection Signs: Monitor for changes in sputum characteristics, increased dyspnea, fever, and elevated WBC count.

Diagnostic Studies

Imaging Studies

High-Resolution CT (HRCT)

Gold Standard for diagnosis

• Shows airway dilation (broncho-arterial ratio >1.5)
• Identifies bronchial wall thickening
• Detects mucus plugging
• Assesses disease extent and distribution

Chest X-Ray

Limited sensitivity (only 50% abnormal)

• Increased lung markings
• Ring shadows (thick-walled cysts)
• Tramline shadows (dilated airways)
• Honeycomb pattern in severe cases

Laboratory Studies

Sputum Analysis

Culture & Sensitivity: Identify organisms
Gram Stain: Rapid bacterial identification
AFB Stain: Rule out tuberculosis
Fungal Studies: If indicated

Blood Tests

Complete Blood Count (CBC)
C-Reactive Protein (CRP)
Erythrocyte Sedimentation Rate (ESR)
Immunoglobulin levels
Alpha-1 antitrypsin level

Pulmonary Function Tests

Spirometry Findings

Obstructive Pattern: FEV1/FVC <70%
Reduced FEV1: Severity assessment
Poor Reversibility: Limited response to bronchodilators
Decreased DLCO: In advanced disease

Severity Classification

Mild: FEV1 ≥80% predicted

Moderate: FEV1 50-79% predicted

Severe: FEV1 30-49% predicted

Very Severe: FEV1 <30% predicted

Specialized Tests

Sweat Chloride Test

For cystic fibrosis screening (>60 mEq/L abnormal)

Nasal Nitric Oxide

For primary ciliary dyskinesia (low levels)

Aspergillus Testing

IgG, IgE levels and precipitins

Genetic Testing

CFTR mutations, other genetic causes

Nursing Considerations for Diagnostics

Pre-procedure: Ensure patient understanding, obtain informed consent for invasive procedures, assess allergies (contrast agents).

During procedure: Provide emotional support, monitor vital signs, assist with proper positioning for imaging.

Post-procedure: Monitor for complications, ensure follow-up appointments, provide result interpretation support.

Sputum Collection: Early morning samples preferred, teach proper collection technique, ensure adequate hydration.

Medical Management

Pharmacological Treatment

Antibiotics

Acute Exacerbations:

• Oral: Amoxicillin-clavulanate, fluoroquinolones
• IV: Ceftazidime, piperacillin-tazobactam
• Duration: 10-14 days typically

Chronic Suppression:

• Inhaled tobramycin or aztreonam
• Oral azithromycin (anti-inflammatory effect)

Bronchodilators

• Short-acting: Albuterol (rescue therapy)
• Long-acting: Formoterol, salmeterol
• Anticholinergics: Ipratropium, tiotropium
• Combination inhalers when indicated

Airway Clearance

Mucolytics

Hypertonic Saline (3-7%): Inhaled
Dornase alfa: For CF-related disease
N-acetylcysteine: Oral or inhaled
Carbocysteine: Oral mucoregulator

Physical Therapy

• Chest physiotherapy (CPT)
• High-frequency chest wall oscillation
• Positive expiratory pressure (PEP) devices
• Active cycle of breathing techniques
• Exercise and pulmonary rehabilitation

Treatment Memory Aid: “CLEAR AIRWAYS”

C – Chest physiotherapy

L – Long-term antibiotics

E – Exercise and rehabilitation

A – Anti-inflammatory therapy

R – Respiratory hygiene

A – Airway clearance devices

I – Immunizations (flu, pneumonia)

R – Routine monitoring

W – Water/hydration

A – Avoid respiratory irritants

Y – Yearly exacerbation prevention

S – Surgical options (if severe)

Surgical Options

Indications for Surgery

• Localized disease with recurrent infections
• Massive hemoptysis
• Failed medical management
• Good candidate for lung transplantation

Surgical Procedures

• Lobectomy or segmentectomy
• Lung transplantation (end-stage disease)
• Bronchial artery embolization (hemoptysis)

Supportive Care

Oxygen Therapy

For hypoxemic patients (SpO2 <90%)

Nutritional Support

High-calorie, high-protein diet; vitamin supplementation

Vaccinations

Annual influenza, pneumococcal, COVID-19

Psychosocial Support

Counseling, support groups, patient education

Nursing Management

Priority Nursing Diagnoses

Primary Diagnoses

1. Ineffective airway clearance related to excessive mucus production
2. Impaired gas exchange related to ventilation-perfusion mismatch
3. Activity intolerance related to impaired oxygen transport
4. Risk for infection related to impaired respiratory defense

Secondary Diagnoses

5. Imbalanced nutrition related to increased metabolic demands
6. Disturbed sleep pattern related to persistent cough
7. Anxiety related to chronic illness and dyspnea
8. Deficient knowledge regarding disease management

Nursing Goals & Outcomes

Short-term Goals (1-7 days)

• Patient will maintain patent airway
• SpO2 will remain >90% on prescribed oxygen
• Patient will demonstrate effective coughing
• Patient will verbalize reduced dyspnea
• Patient will be afebrile within 48-72 hours

Long-term Goals (weeks-months)

• Patient will demonstrate improved exercise tolerance
• Patient will experience fewer exacerbations
• Patient will maintain optimal nutritional status
• Patient will demonstrate self-care independence
• Patient will report improved quality of life

Nursing Interventions

Respiratory Interventions

• Position patient in semi-Fowler’s or high-Fowler’s
• Encourage deep breathing and coughing exercises
• Administer prescribed bronchodilators
• Perform or teach chest physiotherapy
• Monitor oxygen saturation continuously
• Suction airway if patient cannot clear secretions

Infection Control

• Monitor vital signs every 4 hours
• Collect sputum specimens as ordered
• Administer antibiotics as prescribed
• Implement standard precautions
• Encourage hand hygiene
• Monitor for signs of medication adverse effects

Evidence-Based Nursing Practices

Airway Clearance: Research shows that combining multiple airway clearance techniques is more effective than single methods. Rotate between CPT, PEP devices, and active breathing techniques.

Medication Administration: Pre-treat with bronchodilators 15-30 minutes before chest physiotherapy to optimize airway clearance and reduce bronchospasm.

Patient Education: Studies indicate that structured self-management education reduces hospitalizations by up to 40% in bronchiectasis patients.

Exercise Prescription: Pulmonary rehabilitation programs show significant improvement in 6-minute walk distance and quality of life scores.

Nursing Implementation in Clinical Practice

Acute Care Implementation

Emergency Department

Triage Priority: ESI Level 3-4 depending on severity
Initial Assessment: ABCDE approach, oxygen saturation
Interventions: Oxygen therapy, bronchodilators, IV access
Monitoring: Vital signs q15min initially
Preparation: Chest X-ray, ABGs, sputum culture

Inpatient Unit

Admission: Comprehensive assessment, medication reconciliation
Daily Care: CPT 2-4 times/day, medication administration
Monitoring: I&O, daily weights, SpO2, respiratory status
Discharge Planning: Begin on admission day

Community/Home Care

Outpatient Clinic

Routine Visits: Every 3-6 months for stable patients
Assessment: Symptom tracking, functional status
Education: Device technique review, medication compliance
Prevention: Vaccination status, exacerbation planning

Home Health

Initial Visit: Comprehensive home assessment
Equipment: Oxygen, nebulizers, airway clearance devices
Caregiver Training: CPT techniques, medication management
Coordination: With respiratory therapists, physicians

Patient Education Implementation

Disease Understanding

• Pathophysiology explanation
• Chronic nature of condition
• Importance of adherence
• Role of prevention
• When to seek help

Self-Management Skills

• Proper inhaler technique
• Airway clearance methods
• Symptom monitoring
• Action plan development
• Equipment maintenance

Lifestyle Modifications

• Nutrition optimization
• Exercise recommendations
• Smoking cessation
• Environmental control
• Stress management

Interdisciplinary Collaboration

Team Members

Pulmonologist: Medical management, treatment adjustments
Respiratory Therapist: Airway clearance, device training
Physical Therapist: Exercise prescription, rehabilitation
Dietitian: Nutritional optimization, supplement recommendations
Pharmacist: Medication reconciliation, adherence support
Social Worker: Resource coordination, psychosocial support

Quality Metrics

Outcome Measures

Clinical Outcomes:

• Exacerbation frequency
• Hospital readmission rates
• Pulmonary function trends

Patient-Reported Outcomes:

• Quality of life scores (SGRQ-C)
• Symptom severity ratings
• Functional capacity (6MWT)

Best Practice Implementation Tips

1. Standardize Care: Use evidence-based protocols and standardized order sets to ensure consistent, high-quality care across all settings.

2. Patient-Centered Approach: Involve patients in care planning and decision-making. Respect cultural preferences and individual needs.

3. Continuous Monitoring: Implement regular assessment schedules and use validated tools for symptom tracking and quality of life measurement.

4. Care Transitions: Ensure seamless transitions between care settings with comprehensive communication and follow-up protocols.

5. Professional Development: Stay current with evidence-based practice through continuing education and professional organization participation.

Key Takeaways for Nursing Students

Critical Points to Remember

1. Bronchiectasis is irreversible – focus on symptom management
2. Airway clearance is the cornerstone of therapy
3. Early recognition prevents complications
4. Patient education is crucial for self-management
5. Interprofessional collaboration optimizes outcomes
6. Prevention of exacerbations is key to quality of life

NCLEX-Style Practice Point

Priority Nursing Action: When caring for a patient with bronchiectasis experiencing increased dyspnea and purulent sputum, the nurse’s priority action is to:

Answer: Position the patient in high-Fowler’s position and encourage coughing and deep breathing to facilitate airway clearance.

Rationale: Optimizing ventilation and airway clearance addresses the immediate physiological need.

Remember: The Art and Science of Nursing

“Caring for patients with bronchiectasis requires both clinical expertise and compassionate understanding. Your role as a nurse extends beyond medication administration to include education, advocacy, and emotional support for patients managing a chronic, progressive condition.”

Table of Contents

Visual Learning Aid